US SEC Sues Over Alleged Fraud in Virgin Orbit Bailoutby Mark Eisenberg 18.06.2024SEC sues Matthew Brown for a fraudulent $200M bailout of Richard Branson's Virgin Orbit, accusing him of falsifying financial data ...
Elon Musk’s Tweets: How They Shook the Crypto Marketby John Darbie 18.06.2024Explore Elon Musk’s powerful impact on crypto markets through his tweets, causing significant gains and losses for Bitcoin, Dogecoin, and ...
Peru PM: China’s Investments Won’t Alienate US, Welcomes Moreby John Darbie 18.06.2024Peru's PM reassures no US resentment over growing Chinese investments as President Boluarte prepares for key meetings in China.
Ethereum ETFs Anticipated in July: ETH Price to Hit $6,000?by John Darbie 18.06.2024Ethereum ETFs may launch by July 2, per Bloomberg analyst Eric Balchunas; SEC groundwork nearly done, ETH price could reach ...
Mitigating Cyber Breach Liability: Key Strategies for NH Businessesby Lilu Anderson 17.06.2024Learn how to handle a cyber breach effectively with our guide on minimizing damage, reducing liability, and maintaining customer trust.
Aerovate Therapeutics Stock Downgraded After Trial Setbackby Mark Eisenberg 17.06.2024Aerovate Therapeutics stock downgraded by BTIG after AV-101 trial setback; mixed analyst views and future pivotal readouts crucial for investors.
Dollar Eases Against Euro Amid European Political Stabilityby Mark Eisenberg 17.06.2024Dollar weakens against euro as French political jitters ease; euro recovers 0.1%. U.S. data and global currencies watch Federal Reserve ...
Bitcoin Nears $65K: Is It a Bellwether for Market Weakness?by John Darbie 17.06.2024Bitcoin nears $65,000 amid selling pressure, highlighting market vulnerabilities. Key events like Tuesday's retail sales report could impact trends.
XRP Price Surge: Why XRP Outperforms Bitcoin’s Struggleby John Darbie 17.06.2024XRP's price fluctuates near $0.5; increased whale activity and market volatility highlight potential movements. Bitcoin steadies above $65,000.
Roche’s Hemlibra Battles Fierce Competition Amid Rating Holdby Mark Eisenberg 17.06.2024Roche's Hemlibra braces for fierce competition from Novo Nordisk's mim8, as analysts give mixed ratings and forecasts on Roche's strategic ...